Syngene is an integrated CRO/CDMO serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. We offer end-to-end development and manufacturing services to advance clinical candidates from preclinical to NDA filing with ease. Our high-end capabilities for small molecules and biologics extend across drug substance, drug product, analytical development, ICH stability studies, commercial manufacturing, and clinical development.